Roche Medicaments

Roche Holdings: Hold If You Have It, But Do Not...

en

Pharmaceutical Technology

EMA CHMP recommends approval for Roche’s therap...

Roche | Our pharmaceuticals

Roche | Pharma Partnering Contact page

Roche Romania implements new distribution model...

Roche enters obesity drug market with Carmot deal

A history of Roche

Roche | Roche Pharma

FDA Approves Roche Immunotherapy for Bladder Ca...

Roche Pharmaceutical Company Name On Labels Sto...

Roche - Pharmaceutical Business review

Roche Pharma enters ophthalmology segment

Roche Pharmaceuticals – Element Data

Roche’s MS Drug Reports Promising Results - WSJ

After Failed Tests: Roche Pulls the Plug on Bre...

Obesity drug from Roche shows promise in early ...

Roche, Blueprint lung cancer drug wins FDA appr...

Roche Says Drug Meets Bladder Cancer Target - WSJ

Roche Revenue Lifted by Cancer and Immunology D...

Pharma Careers for Doctors at Roche – Medic Foo...

Switzerland's Roche reports promising results f...

Qui sommes-nous ? | Roche

Roche scraps Alzheimer’s drug trials after fail...

Roche Pharmaceuticals (division of Roche Group)...

Roche | Pharma

Roche - Pharma Journal

Roche buys U.S. rights to Roivant bowel disease...

Roche and Exelixis detail rare success for Cabo...

Roche begins new clinical trials of multiple sc...

Roche Announces $250M Deal to Acquire Good Ther...

Roche Fights Roche for $9 Billion Drug Business...

Roche Sales Rise on Cancer Drugs - WSJ

New Cancer Immunotherapy Fails in First Roche T...